# Studying the Efficacy of Aspirin & Clopidogrel in Healthy Subjects With Stable Coronary Artery Disease.

> **NCT01011257** · PHASE4 · WITHDRAWN · sponsor: **Neil Kleiman, MD**

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Asprin
- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT01011257
- **Lead sponsor:** Neil Kleiman, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-09
- **Primary completion:** 2011-08
- **Final completion:** 2011-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No funding secured.
- **Last updated:** 2018-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01011257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01011257, "Studying the Efficacy of Aspirin & Clopidogrel in Healthy Subjects With Stable Coronary Artery Disease.". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT01011257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*